Back to News
Market Impact: 0.2
Here's Why Tyra Biosciences (TYRA) is Poised for a Turnaround After Losing 27% in 4 Weeks
Source: zacks.com
Market Technicals & FlowsAnalyst EstimatesAnalyst Insights
Tyra Biosciences is described as technically oversold, suggesting selling pressure may have eased. The article says strong agreement among Wall Street analysts in raising earnings estimates could support a trend reversal, but provides no specific estimate changes or share-price data.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
TYRA0.45
More News
- Why is Samsung Electronics stock plunging today?
- SK Hynix plunges 8% amid Asia tech rout as Fed rate hike fears, AI funding worries mount
- SK Hynix seeks U.S. chip equipment exports to China tied to new factory
- Hot September CPI Spurs Fed Rate Hike Fears
- Dell stock plunges 11%, leading data center sell-off on concerns about 'enterprise AI timing'
- Why is Rocket Lab stock tumbling today?
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Research Workflows, Report Format Selection, and Interactive Synthesis
- Can ChatGPT Analyze a 10-K? A Verification Workflow